These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

694 related items for PubMed ID: 15593036

  • 21. Darbepoetin alfa effectively treats anemia in patients with chronic kidney disease with de novo every-other-week administration.
    Toto RD, Pichette V, Navarro J, Brenner R, Carroll W, Liu W, Roger S.
    Am J Nephrol; 2004; 24(4):453-60. PubMed ID: 15331889
    [Abstract] [Full Text] [Related]

  • 22. A comparison of haemoglobin levels and doses in haemodialysis patients treated with subcutaneous or intravenous darbepoetin alfa: a German prospective, randomized, multicentre study.
    Bommer J, Asmus G, Wenning M, Bommer G.
    Nephrol Dial Transplant; 2008 Dec; 23(12):4002-8. PubMed ID: 18676350
    [Abstract] [Full Text] [Related]

  • 23. Australian haemodialysis patients on intravenous epoetin alfa or intravenous darbepoetin alfa: how do they compare?
    Pussell BA, Walker R, Australian Renal Anaemia Group.
    Nephrology (Carlton); 2007 Apr; 12(2):126-9. PubMed ID: 17371333
    [Abstract] [Full Text] [Related]

  • 24. An open-label study of darbepoetin alfa administered once monthly for the maintenance of haemoglobin concentrations in patients with chronic kidney disease not receiving dialysis.
    Agarwal AK, Silver MR, Reed JE, Dhingra RK, Liu W, Varma N, Stehman-Breen C.
    J Intern Med; 2006 Dec; 260(6):577-85. PubMed ID: 17116009
    [Abstract] [Full Text] [Related]

  • 25. Correction of anaemia with darbepoetin alfa in patients with chronic kidney disease receiving dialysis.
    Macdougall IC, Matcham J, Gray SJ, NESP 960245/246 Study Group.
    Nephrol Dial Transplant; 2003 Mar; 18(3):576-81. PubMed ID: 12584282
    [Abstract] [Full Text] [Related]

  • 26. [Italian study on the treatment of anaemia in chronic dialysis patients switched over to less frequent doses of darbepoetin from human recombinant erythropoietin (rHuEPO)].
    Del Vecchio L, Villa G, Carraro G, Morosetti M, Pedrini L, Adorati Menegato M, Amato M, Mauro MM, Borgatti P, Malberti F, Marai P, Locatelli F, Gruppo Di Studio NESP 2000 0116 (NESP 3b).
    G Ital Nefrol; 2004 Mar; 21(3):259-66. PubMed ID: 15285005
    [Abstract] [Full Text] [Related]

  • 27. Darbepoetin alfa once every 2 weeks for treatment of anemia in dialysis patients: a combined analysis of eight multicenter trials.
    Mann J, Kessler M, Villa G, Martinez-Castelao A, Feldt-Rasmussen B, Cruz J, Hörl WH, Mattin C, Praml C, Wilkie M.
    Clin Nephrol; 2007 Mar; 67(3):140-8. PubMed ID: 17390738
    [Abstract] [Full Text] [Related]

  • 28. Darbepoetin alfa administered every three weeks is effective for the treatment of chemotherapy-induced anemia.
    Boccia R, Malik IA, Raja V, Kahanic S, Liu R, Lillie T, Tomita D, Clowney B, Silberstein P.
    Oncologist; 2006 Apr; 11(4):409-17. PubMed ID: 16614237
    [Abstract] [Full Text] [Related]

  • 29. Oxidative stress, inflammation and nutritional status during darbepoetin alpha treatment in peritoneal dialysis patients.
    Malgorzewicz S, Lichodziejewska-Niemierko M, Lizakowski S, Liberek T, Lysiak-Szydlowska W, Rutkowski B.
    Clin Nephrol; 2010 Mar; 73(3):210-5. PubMed ID: 20178720
    [Abstract] [Full Text] [Related]

  • 30. [Feasibility strategy of darbepoetin alfa administration every other week: 2005-2007 experience in a dialysis unit].
    Rottembourg JB, Dansaert A.
    Nephrol Ther; 2011 Dec; 7(7):549-57. PubMed ID: 21622039
    [Abstract] [Full Text] [Related]

  • 31. Treatment of anemia with darbepoetin alfa administered de novo once every other week in chronic kidney disease.
    Suranyi MG, Lindberg JS, Navarro J, Elias C, Brenner RM, Walker R.
    Am J Nephrol; 2003 Dec; 23(2):106-11. PubMed ID: 12481149
    [Abstract] [Full Text] [Related]

  • 32. Comparison of darbepoetin alfa and epoetin alfa in the management of anemia of critical illness.
    Voils SA, Harpe SH, Brophy GM.
    Pharmacotherapy; 2007 Apr; 27(4):535-41. PubMed ID: 17381380
    [Abstract] [Full Text] [Related]

  • 33. Darbepoetin alfa administered once monthly maintains hemoglobin concentrations in patients with chronic kidney disease.
    Ling B, Walczyk M, Agarwal A, Carroll W, Liu W, Brenner R.
    Clin Nephrol; 2005 May; 63(5):327-34. PubMed ID: 15909591
    [Abstract] [Full Text] [Related]

  • 34. Reengineering clinical operations in a medical practice to optimize the management of anemia of chronic kidney disease.
    Joy MS, Candiani C, Vaillancourt BA, Chin H, Hogan SL, Falk RJ.
    Pharmacotherapy; 2007 May; 27(5):734-44. PubMed ID: 17461709
    [Abstract] [Full Text] [Related]

  • 35. Randomized equivalence study evaluating the possibility of switching hemodialysis patients receiving subcutaneous human erythropoietin directly to intravenous darbepoetin alfa.
    Chazot C, Terrat JC, Dumoulin A, Ang KS, Gassia JP, Chedid K, Maurice F, Canaud B, Conference Medical Group.
    Ann Pharmacother; 2009 Feb; 43(2):228-34. PubMed ID: 19407262
    [Abstract] [Full Text] [Related]

  • 36. Darbepoetin alfa administered every three weeks (Q3W) in anemic cancer patients receiving chemotherapy (CT).
    Martelli O, Garassino M, Sacchetta S, Caristo R, Zivi A, Cerbone L, Mancuso A.
    Anticancer Res; 2008 Feb; 28(3B):1767-71. PubMed ID: 18630457
    [Abstract] [Full Text] [Related]

  • 37. C.E.R.A. once every 4 weeks in patients with chronic kidney disease not on dialysis: The ARCTOS extension study.
    Kessler M, Martínez-Castelao A, Siamopoulos KC, Villa G, Spinowitz B, Dougherty FC, Beyer U.
    Hemodial Int; 2010 Apr; 14(2):233-9. PubMed ID: 19888948
    [Abstract] [Full Text] [Related]

  • 38. Developing an algorithm to convert erythropoietin dosing to darbepoetin alfa.
    Capelli JP, Kushner H.
    Nephrol News Issues; 2006 Mar; 20(3):33, 35, 39 passim. PubMed ID: 16532992
    [Abstract] [Full Text] [Related]

  • 39. Darbepoetin alfa once monthly corrects anaemia in patients with chronic kidney disease not on dialysis.
    Roger SD, Kolmakova E, Fung M, Malecki R, Vinhas J, Dellanna F, Thomas M, Manamley N, Ferenczi S.
    Nephrology (Carlton); 2014 May; 19(5):266-74. PubMed ID: 24506498
    [Abstract] [Full Text] [Related]

  • 40. Effect of darbepoetin alfa administered once monthly on maintaining hemoglobin levels in older patients with chronic kidney disease.
    Silver MR, Agarwal A, Krause M, Lei L, Stehman-Breen C.
    Am J Geriatr Pharmacother; 2008 Jun; 6(2):49-60. PubMed ID: 18675764
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.